Apoptotic endothelial cells demonstrate increased adhesiveness for human Mesenchymal stem cells

Journal of Cellular Physiology

Volumn 219, Issue 1, 2009, Pages 23-30

  Potapova, Irina A ^a   Cohen, Ira S ^a   Doronin, Sergey V ^a  

^a STONY BROOK UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOHEXIMIDE; DACTINOMYCIN; HOMING RECEPTOR; INTERLEUKIN 1BETA; OKADAIC ACID; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE; STAUROSPORINE; TUMOR NECROSIS FACTOR ALPHA; VON WILLEBRAND FACTOR; WORTMANNIN; ANDROSTANE DERIVATIVE; ENZYME INHIBITOR; MEMBRANE ANTIGEN; PROTEIN SYNTHESIS INHIBITOR;

APOPTOSIS; ARTICLE; CELL ACTIVITY; CELL ADHESION; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME INHIBITION; HUMAN; HUMAN CELL; INFLAMMATORY CELL; MEMBRANE POTENTIAL; MESENCHYMAL STEM CELL; MITOCHONDRIAL MEMBRANE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TISSUE INJURY; ANIMAL; CELL CULTURE; CYTOLOGY; DRUG EFFECT; METABOLISM; MITOCHONDRIAL MEMBRANE POTENTIAL; PHYSIOLOGY;

MAMMALIA;

ANDROSTADIENES; ANIMALS; ANTIGENS, SURFACE; APOPTOSIS; CELL ADHESION; CELLS, CULTURED; CYCLOHEXIMIDE; ENDOTHELIAL CELLS; ENZYME INHIBITORS; HUMANS; INTERLEUKIN-1BETA; MEMBRANE POTENTIAL, MITOCHONDRIAL; MESENCHYMAL STEM CELLS; NADH DEHYDROGENASE; OKADAIC ACID; PROTEIN SYNTHESIS INHIBITORS; SIGNAL TRANSDUCTION; STAUROSPORINE; TUMOR NECROSIS FACTOR-ALPHA; VON WILLEBRAND FACTOR;

EID: 60849117797     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcp.21645     Document Type: Article

References (48)

1. Assmus B, Fischer-Rasokat U, Honold J, Seeger FH, Fichtlscherer S, Tonn T, Seifried E, Schachinger V, Dimmeler S, Zeiher AM. 2007. Transcoronary transplantation of functionally competent BMCs is associated with a decrease in natriuretic peptide serum levels and improved survival of patients with chronic postinfarction heart failure: Results of the TOPCARE-CHD registry. Circ Res 100:1234-1241.
2. Barbash IM, Chouraqui P, Baron J, Feinberg MS, Etzion S, Tessone A, Miller L, Guetta E, Zipori D, Kedes LH, Kloner RA, Leor J. 2003. Systemic delivery of bone marrow-derived mesenchymal stem cells to the infarcted myocardium: Feasibility, cell migration, and body distribution. Circulation 108:863-868.
3. Bittira B, Shum-Tim D, Al-Khaldi A, Chiu RCJ. 2003. Mobilizationand homing of bone marrow stromal cells in myocardial infarction. Eur J Cardiothorac Surg 24:393-398.
4. Blann A. 1993. von Willebrand factor and the endothelium in vascular disease. Br J Biomed Sci 50:125-134.
5. Bombeli T, Schwartz BR, Harlan JM. 1999. Endothelial cells undergoing apoptosis become proadhesive for nonactivated platelets. Blood 93:3831-3838.
6. Cavender D, Haskard D, Foster N, Ziff M. 1987. Superinduction of T lymphocyte-endothelial cell (EC) binding by treatment of EC with interleukin 1 and protein synthesis inhibitors. J Immunol 138:2149-2154.
7. Chapel A, Bertho JM, Bensidhoum M, Fouillard L, Young RG, Frick J, Demarquay C, Cuvelier F, MathieuE, Trompier F, DudoignonN, Germain C, MazurierC, Aigueperse J, BornemanJ, GorinNC, GourmelonP, Thierry D.2003. Mesenchymal stem cells home to injured tissues when co-infused with hematopoietic cells to treat a radiation-induced multi-organ failure syndrome. J Gene Med 5:1028-1038.
8. Chen PL, Easton A. 2008. Apoptotic phenotype alters the capacity of tumor necrosis factor- related apoptosis-inducing ligand to induce human vascular endothelial activation. J Vasc Res 45:111-122.
9. Cheng Z, Ou L, Zhou X, Li F, Jia X, Zhang Y, Liu X, Li Y, Ward CA, Melo LG, Kong D. 2008. Targeted migration of mesenchymal stem cells modified with CXCR4 gene to infarcted myocardium improves cardiac performance. Mol Ther 16:571-579.
10. Devine MJ, Mierisch CM, Jang E, Anderson PC, Balian G. 2002. Transplanted bone marrow cells localize to fracture callus in a mouse model. J Orthop Res 20:1232-1239.
11. Dimmeler S, Burchfield J, Zeiher AM. 2008. Cell-based therapy of myocardial infarction. Arterioscler Thromb Vasc Biol 28:208-216.
12. Erbs S, Linke A, Schachinger V, Assmus B, Thiele H, Diederich K-W, Hoffmann C, Dimmeler S, Tonn T, Hambrecht R, Zeiher AM, Schuler G. 2007. Restoration of microvascular function in the infarct-related artery by intracoronary transplantation of bone marrow progenitor cells in patients with acute myocardial infarction: The Doppler substudy of the reinfusion of enriched progenitor cells and infarct remodeling in acute myocardial infarction (REPAIR-AMI) trial. Circulation 116:366-374.
13. Galli D, Innocenzi A, Staszewsky L, Zanetta L, Sampaolesi M, Bai A, Martinoli E, Carlo E, Balconi G, Fiordaliso F, Chimenti S, Cusella G, Dejana E, Cossu G, Latini R. 2005. Mesoangioblasts, vessel-associated multipotent stem cells, repair the infarcted heart by multiple cellular mechanisms: A comparison with bone marrow progenitors, fibroblasts, and endothelial cells. Arterioscler Thromb Vasc Biol 25:692-697.
14. Gonzalez MA, Selwyn AP. 2003. Endothelial function, inflammation, and prognosis in cardiovascular disease. Am J Med 115:99-106.
15. Ip JE, Wu Y, Huang J, Zhang L, Pratt RE, Dzau VJ. 2007. Mesenchymal stem cells use integrin beta1 not CXC chemokine receptor 4 for myocardial migration and engraftment. Mol Biol Cell 18:2873-2882.
16. Ji JF, He BP, Dheen ST, Tay SSW. 2004. Interactions of chemokines and chemokine receptors mediate the migration of mesenchymal stem cells to the impaired site in the brain after hypoglossal nerve injury. Stem Cells 22:415-427.
17. Kraitchman DL, Tatsumi M, Gilson WD, Ishimori T, Kedziorek D, Walczak P, Segars WPH, Chen H, Fritzges D, Izbudak I, Young RG, Marcelino M, Pittenger MF, Solaiyappan M, Boston RC, Tsui BMW, Wahl RL, Bulte JWM. 2005. Dynamic imaging of allogeneic mesenchymal stem cells trafficking to myocardial infarction. Circulation 112:1451-1461.
18. Mansilla E, Marin GH, Drago H, Sturla F, Salas E, Gardiner C, Bossi S, Lamonega R, Guzman A, Nucez A, Gil MA, Piccinelli G, Ibar R, Soratti C. 2006. Bloodstream cells phenotypically identical to human mesenchymal bone marrow stem cells circulate in large amounts under the influence of acute large skin damage: New evidence for their use in regenerative medicine. Transplant Proc 38:967-969.
19. Mazhari R, Hare JM. 2007. Mechanisms of action of mesenchymal stem cells in cardiac repair: Potential influences on the cardiac stem cell niche. Nat Clin Pract Cardiovasc Med 4:S21-S26.
20. Mosca JD, Hendricks JK, Buyaner D, Davis-Sproul J, Chuang LC, Majumdar MK, Chopra R, Barry F, Murphy M, Thiede MA, Junker U, Rigg RJ, Forestell SP, Bohnlein E, Storb R, Sandmaier BM. 2000. Mesenchymal stem cells as vehicles for gene delivery. Clin Orthop Relat Res 379:S71-S90.
21. Mouiseddine M, Francois S, Semont A, Sache A, Allenet B, Mathieu N, Frick J, Thierry D, Chapel A. 2007. Human mesenchymal stem cells home specifically to radiation-injured tissues in a non-obese diabetes/severe combined immunodeficiency mouse model. Br J Radiol 80:S49-S55.
22. Nagata S. 1997. Apoptosis by death factor. Cell 88:355-365.
23. Pober JS. 1998. Activation and injury of endothelial cells by cytokines. Pathol Biol (Paris) 46:159-163.
24. Pohlman TH, Harlan JM. 1989. Human endothelial cell response to lipopolysaccharide, interleukin-1, and tumor necrosis factor is regulated by protein synthesis. Cell Immunol 119:41-52.
25. Pohlman TH, Harlan JM. 2000. Adaptive responses of the endothelium to stress. J Surg Res 89:85-119.
26. Polunovsky VA, Wendt CH, Ingbar DH, Peterson MS, Bitterman PB. 1994. Induction of endothelialcell apoptosis by TNF[alpha]: Modulation by inhibitors of protein synthesis. Exp Cell Res 214:584-594.
27. Potapova IA, Gaudette GR, Brink PR, Robinson RB, Rosen MR, Cohen IS, Doronin SV. 2007. Mesenchymal stem cells support migration,extracellular matrix invasion, proliferation, and survival of endothelial cells in vitro. Stem Cells 25:1761-1768.
28. Potapova IA, Brink PR, Cohen IS, Doronin SV. 2008. Culturing of human mesenchymal stem cells as 3D-aggregates induces functional expression of CXCR4 that regulates adhesion to endothelial cells. J Biol Chem 283:13100-13107.
29. Ramirez M, Lucia A, Gomez-Gallego F, Esteve-Lanao J, Perez-Martinez A, Foster C, Andreu AL, Martin MA, Madero L, Arenas J, Garcia-Castro J. 2006. Mobilisation of mesenchymal cells into blood in response to skeletal muscle injury. Br J Sports Med 40:719-722.
30. Reers M, Smiley ST, Mottola-Hartshorn C, Chen A, Lin M, Chen LB. 1995. Mitochondrial membrane potential monitored by JC-1 dye. Methods Enzymol 260:406-417.
31. Riedl SJ, Salvesen GS. 2007. The apoptosome: Signalling platform of cell death. Nat Rev Mol Cell Biol 8:405-413.
32. Rombouts WJC, Ploemacher RE. 2003. Primary murine MSC show highly efficient homing to the bone marrow but lose homing ability following culture. Leukemia 17:160-170.
33. Ruggeri ZM, Ware J. 1993. von Willebrand factor. FASEB J 7:308-316.
34. Ruster B, Gottig S, Ludwig RJ, Bistrian R, Muller S, Seifried E, Gille J, Henschler R. 2006. Mesenchymal stem cells display coordinated rolling and adhesion behavior on endothelial cells. Blood 108:3938-3944.
35. Scarabelli T, Stephanou A, Rayment N, Pasini E, Comini L, Curello S, Ferrari R, Knight R, Latchman D. 2001. Apoptosis of endothelial cells precedes myocyte cell apoptosis in ischemia/reperfusion injury. Circulation 104:253-256.
36. Schachinger V, Erbs S, Elsasser A, Haberbosch W, Hambrecht R, Holschermann H, Yu J, Corti R, MatheyDG, Hamm CW,SuselbeckT, Assmus B, Tonn T, Dimmeler S, Zeiher AM, the R-AMII. 2006a. Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction. N Engl J Med 355:1210-1221.
37. Schachinger V, Erbs S, Elsasser A, Haberbosch W, Hambrecht R, Holschermann H, Yu J, Corti R, Mathey DG, Hamm CW, Suselbeck T, Werner N, Haase J, Neuzner J, Germing A, Mark B, Assmus B, Tonn T, Dimmeler S, Zeiher AM, for the R-AMII. 2006b. Improved clinical outcome after intracoronary administration of bone-marrow-derived progenitor cells in acute myocardial infarction: Final 1-year results of the REPAIR-AMI trial. Eur Heart J 27:2775-2783.
38. Schmidt A, Ladage D, Steingen C, Brixius K, Schinkothe T, Klinz F-J, Schwinger RHG, Mehlhorn U, Bloch W. 2006. Mesenchymal stem cells transmigrate over the endothelial barrier. Eur J Cell Biol 85:1179-1188.
39. Seeger FH, Tonn T, Krzossok N, Zeiher AM, Dimmeler S. 2007a. Cell isolation procedures matter: A comparison of different isolation protocols of bone marrow mononuclear cells used for cell therapy in patients with acute myocardial infarction. Eur Heart J 28:766-772.
40. Seeger FH, Zeiher AM, Dimmeler S. 2007b. Cell-enhancement strategies for the treatment of ischemic heart disease. Nat Clin Pract Cardiovasc Med 4:S110-S113.
41. Spiel AO, Gilbert JC, Jilma B. 2008. von Willebrand factor in cardiovascular disease: Focus on acute coronary syndromes. Circulation 117:1449-1459.
42. Varga-Szabo D, Pleines I, Nieswandt B. 2008. Cell adhesion mechanisms in platelets. Arterioscler Thromb Vasc Biol 28:403-412.
43. Wang L, Li Y, Chen J, Gautam SC, Zhang Z, Lu M, Chopp M. 2002. Ischemic cerebral tissue and MCP-1 enhance rat bone marrow stromal cell migration in interface culture. Exp Hematol 30:831-836.
44. Wang Y, Johnsen HE, Mortensen S, Bindslev L, Ripa RS, Haack-Sorensen M, Jorgensen E, Fang W, Kastrup J. 2006. Changes in circulating mesenchymal stem cells, stem cell homing factor, and vascular growth factors in patients with acute ST elevation myocardial infarction treated with primary percutaneous coronary intervention. Heart 92:768-774.
45. Wang Y, Deng Y, Zhou GQ. 2008. SDF-1alpha/CXCR4-mediated migration of systemically transplanted bone marrow stromal cells towards ischemic brain lesion in a rat model. Brain Res 1195:104-112.
46. Wynn RF, Hart CA, Corradi-Perini C, O'Neill L, Evans CA, Wraith JE, Fairbairn LJ, Bellantuono I. 2004. A small proportion of mesenchymal stem cells strongly expresses functionally active CXCR4 receptor capable of promoting migration to bone marrow. Blood 104:2643-2645.
47. Zhang S, Ge J, Sun A, Xu D, Qian J, Lin J, Zhao Y, Hu H, Li Y, Wang K, Zou Y. 2006. Comparison of various kinds of bone marrow stem cells for the repair of infarcted myocardium: Single clonally purified non-hematopoietic mesenchymal stem cells serve as a superior source. J Cell Biochem 99:1132-1147.
48. Zhang D, Fan GC, Zhou X, Zhao T, Pasha Z, Xu M, Zhu Y, Ashraf M, Wang Y. 2008. Over-expression of CXCR4 on mesenchymal stem cells augments myoangiogenesis in the infarcted myocardium. J Mol Cell Cardiol 44:281-292.